Opexa Pharmaceuticals, Inc. Reports First Quarter 2008 Financial Results and Updates on Tovaxin(R) Phase IIb Study
THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company involved in the development and commercialization of cell therapies, today reported financial results for the quarter ended March 31, 2008 and provided an update on its progress.